News
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by Fujirebio Diagnostics, is simple: Early detection of beta-amyloid plaques linked to the neurocognitive disease in adults 55 and older who are exhibiting signs and symptoms of the disorder.
The test will initially be available at about 50 American research institutes and hospitals that specialize in Alzheimer’s ...
MIT and Harvard scientists have discovered potential new targets for treating or preventing Alzheimer's disease.
Journalist and women’s health advocate Maria Shriver discusses an important new advance in the fight against Alzheimer’s ...
By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.
2025 — Learning about one's risk for Alzheimer's disease may not lead to emotional distress, but motivation to maintain healthy lifestyle changes tends to ... Most People Say They Want to Know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback